BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19023830)

  • 1. The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy.
    Lewis SA; Haw SJ; McNeill A
    Nicotine Tob Res; 2008 Dec; 10(12):1789-92. PubMed ID: 19023830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-the-counter availability of nicotine replacement therapy and smoking cessation.
    Hyland A; Rezaishiraz H; Giovino G; Bauer JE; Michael Cummings K
    Nicotine Tob Res; 2005 Aug; 7(4):547-55. PubMed ID: 16085526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of media campaigns on smoking cessation activity: a structural vector autoregression analysis.
    Langley TE; McNeill A; Lewis S; Szatkowski L; Quinn C
    Addiction; 2012 Nov; 107(11):2043-50. PubMed ID: 22632403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California.
    Reed MB; Anderson CM; Vaughn JW; Burns DM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2131-6. PubMed ID: 16172221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scottish smoke-free legislation and trends in smoking cessation.
    Fowkes FJ; Stewart MC; Fowkes FG; Amos A; Price JF
    Addiction; 2008 Nov; 103(11):1888-95. PubMed ID: 19032538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of advertising on nicotine replacement therapy demand.
    Tauras JA; Chaloupka FJ; Emery S
    Soc Sci Med; 2005 May; 60(10):2351-8. PubMed ID: 15748682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
    Szatkowski L; Coleman T; McNeill A; Lewis S
    Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pharmacy data to evaluate smoking regulations' impact on sales of nicotine replacement therapies in New York City.
    Metzger KB; Mostashari F; Kerker BD
    Am J Public Health; 2005 Jun; 95(6):1050-5. PubMed ID: 15914832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine replacement prescribing trends in a large psychiatric hospital, before and after implementation of a hospital-wide smoking ban.
    Scharf D; Fabian T; Fichter-DeSando C; Douaihy A
    Nicotine Tob Res; 2011 Jun; 13(6):466-73. PubMed ID: 21464201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E; Piekoszewski W
    Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of switching smoking cessation drugs to over-the-counter status.
    Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
    Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Why the ban on smoking should be expanded in Poland?].
    Jankowski P; Kawecka-Jaszcz K; Jassem J; Zdrojewski T; Kopeć G; Podolec P
    Kardiol Pol; 2009 Jan; 67(1):101-5. PubMed ID: 19253200
    [No Abstract]   [Full Text] [Related]  

  • 13. Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness.
    Walsh RA
    Drug Alcohol Rev; 2008 Sep; 27(5):529-47. PubMed ID: 18696300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco quitline use: enhancing benefit and increasing abstinence.
    Campbell SL; Lee L; Haugland C; Helgerson SD; Harwell TS
    Am J Prev Med; 2008 Oct; 35(4):386-8. PubMed ID: 18675528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health or social impacts? A qualitative analysis of attitudes toward the smoke-free legislation in Scotland.
    Heim D; Ross A; Eadie D; MacAskill S; Davies JB; Hastings G; Haw S
    Nicotine Tob Res; 2009 Dec; 11(12):1424-30. PubMed ID: 19875764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?
    Shiffman S; Sweeney CT
    Health Policy; 2008 Apr; 86(1):17-26. PubMed ID: 17935827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface.
    Warner KE; Peck CC; Woosley RL; Henningfield JE; Slade J
    Food Drug Law J; 1998; 53 suppl():1-8. PubMed ID: 10342978
    [No Abstract]   [Full Text] [Related]  

  • 18. Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking.
    Kozlowski LT; Giovino GA; Edwards B; Difranza J; Foulds J; Hurt R; Niaura R; Sachs DP; Selby P; Dollar KM; Bowen D; Cummings KM; Counts M; Fox B; Sweanor D; Ahern F
    Addict Behav; 2007 Oct; 32(10):2140-50. PubMed ID: 17360126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes and knowledge about nicotine and nicotine replacement therapy.
    Mooney ME; Leventhal AM; Hatsukami DK
    Nicotine Tob Res; 2006 Jun; 8(3):435-46. PubMed ID: 16801301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current tobacco control policy trends in the United States.
    Stoner WI; Foley BX
    Clin Occup Environ Med; 2006; 5(1):85-99, ix. PubMed ID: 16446256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.